Document is current

Any future updates will be listed below

Cost-Effectiveness Analysis of Regorafenib for Gastrointestinal Stromal Tumour (GIST) in Germany

Crossref DOI link: https://doi.org/10.1007/s40261-017-0514-3

Published Online: 2017-03-30

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark